Hyperintense basal ganglia on T1-weighted MR sequences in a case of portal-systemic shunt without liver failure;Iperintensita dei nuclei della base nelle sequenze RM T1-W in un caso di shunt porto-sistemico senza insufficienza epatica

Rivista di Neuroradiologia

Volumn 9, Issue 4, 1996, Pages 493-500

  Gozzoli, L ^a   Ambrogio, L ^a   Grasso, M ^a   Ghezzo, L ^a   Magro, G P ^a   Bradac, G B ^b   Bergui, M ^b   Ferro, C ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

basal ganglia; liver cirrhosis; MR; porto systemic shunt

Indexed keywords

MANGANESE;

ADULT; ARTICLE; BASAL GANGLION; CASE REPORT; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIVER CIRRHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTOSYSTEMIC ANASTOMOSIS;

EID: 0029764748     PISSN: 11209976     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140099600900423     Document Type: Article

References (27)

1. Adams RD: Acquired hepatocerebral degeneration. In: Vinken PJ, Bruyn GW (eds): Handbook of clinical neurology. Vol 6. Diseases of the basal ganglia. North-Holland, Amsterdam 1968: 279-297.
2. Barbeau A: Manganese and extrapyramidal disorders. Neurotoxicology 5: 13-361, 1984.
3. Bernthal P, Hays A et Al: Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 7: 107-114, 1987.
4. Brumberg JA, Kanal E et Al: Chronic acquired hepatic failure: MR imaging of the brain at 1,5 T. Am J Neurorad 12: 909-914, 1991.
5. Devenyi AG, Barron TF, Mamourian AC: Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagille's Syndrome. Gastroenterology 106: 1068-1071, 1994.
6. Donaldson J, LaBella FS, Gesser D: Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology 2: 53-64, 1981.
7. Fell JME, Reynolds AP et Al: Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347: 1218-1221, 1996.
8. Finlayson MH, Superville B: Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 104: 79-95, 1981.
9. Griggs RC: Recognition and treatment of hepatic encephalopathy. Annual Course of American Academy of Neurology. Vol VII, course no 226. S. Diego 1995.
10. Hauser RA, Zesiewicz TA et Al: Manganese intoxication and chronic liver failure. Annals of Neurology 36/6: 871-875, 1994.
11. Huang CC, Lu CS et Al: Progression after chronic manganese exposure. Neurology 43: 1479-1483, 1993.
12. Inoue E, Shinichi H et Al: Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 179: 551-555, 1991.
13. Kulisevsky J, Ruscadella J, Grau JM: MR imaging of acquired hepatocerebral degeneration. Am J Neurorad 12: 527-528, 1991.
14. Kulisevski J, Pujol J et Al: Pallidal hyperintesity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 16: 1382-1388, 1992.
15. Kulisevsky J, Pujol J et Al: MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: Two different MRI patterns of clinical deterioration? Neurology 43: 2570-2573, 1993.
16. Kulisevsky J, Pujol J et Al: Persistence of MRI hyperintensity of the globus pallidus in cirrhotic patients: A 2-year follow-up study. Neurology 45: 995-997, 1995.
17. Langston JW: Industrial toxins in Parkinsonism. Annual Course of American Academy of Neurology. Vol. IV, course no 440. S. Francisco 1996.
18. Langston JW: Chemicals and the shakes: designer steel, cloths and drugs. (Story of Parkinsonism among manganese miners, steel and rayon industry & MPTP drugs). Annual Course of American Academy of Neurology. Vol VIII, course no 125. S. Francisco 1996.
19. Laursen H: Cerebral vessels and glial cells in liver disease. A morphometric and electron microscopic investigation. Acta Neurol Scand 65: 381-412, 1982.
20. Mirowitz SA, Westrich TJ Hirsch JD: Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 181: 117-120, 1991.
21. Mirowitz SA,Weistrich TJ: Basal ganglia signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 185: 535-536, 1992.
22. Pujol A, Pujol J et Al: Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 43: 65-69, 1993.
23. Pulsinelli WA, Cooper AJL: Metabolic encephalopathies and coma. In: Basic Neurochemistry, 4th ed. Raven Press, 1989: 765-781.
24. Victor M, Adams RD, Cole M: The acquired (non Wilsonian) type of chronic hepatocerebral degeneration. Medicine 44: 365-395, 1965.
25. Victor M: Neurologic disorders due to alcoholism and malnutrition. In: Clinical Neurology, Vol 4. Lippincott Philadelphia 1986: 72-78.
26. Vymazal J, Babis M et Al: T1 and T2 alterations in the brains of patients with hepatic cirrhosis. Am J Neurorad 17: 333-336, 1996.
27. Zeneroli ML, Cioni G et Al: Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy: evaluation by computed tomography. J Hepatol 4: 283-292, 1987.